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Introduction
Gout probably has been the best
documented of human diseases
throughout the ages. This may be
because it is easily identifiable,
owing not only to the dramatic
nature of its sudden painful, acute
episodes, but also--which may
have pleased the masses-to its
tendency to pick out rather important and wealthy victims. For the
underdog, seeing that sort of person suddenly and unpredictably incapacitated, with his afflicted foot
swathed in monstrous protective
bandages, the disease assumed a
uniquely comic aspect which has
persisted to this day, although
never shared by sufferers from
what the great Dr. Samuel Johnson
described as "the most diabolic
[pain] to which man may be subjected."
Gout was not a word devised by
the medical profession, but rather a
colloquialism used first by the teutonic denizens of the northern outposts of the Roman Empire, for
what the Greeks termed generically
"arthritis," i.e., disease of the joints.
When it affected the great toe, as
true gout frequently does (Fig. 1) ,
they termed it podagra. The term
was based upon the Latin word
gutta (a drop) . According to their
humoral hypothesis , phlegm, one
of the four constituent humours
which made up the human body,
could be distilled in excess and
would then drop into weakened
joint cavities, the distension thus
caused producing the great pain
and swelling typical of the disease.
The first person in modern times
to distinguish between gout and
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rheumatic fever as specific entities
was the 16th century French
Royal Physician Guillaume de Baillou, also called Ballonius ( 1642) .
A little later, the great Thomas
Sydenham independently made the
same differentiation in his classic
and often quoted description, drawing largely upon his own sufferings from the former disease.
The basic cause of the gout, like
that of all other disease processes,
was believed by most physicians of
the early world to lie in an alteration or an imbalance of the body
humours (Fig. 2) . A modified view
is attributed to Aretaeus the Cappadocian (fl. A.O. 135) , however,
who asserted that "the basic cause
of this disease none but the Gods
can ever understand." In the 18th
century, the Age of Reason , gen-

era! medical op1mon was summarised by Dr. Walter Harris, who
wrote that a man may have a
"gouty disposition" even when he
is free of "actual fitts" (diathesis).
He thought, moreover, that "The
Common Opinion as to Wine and
Women is proved unjust and uncharitable."
Here the matter rested until Sir
Alfred Garrod discovered, in 1848,
that the "morbid circulating matter" which had always been assumed to be causative of the gouty
diathesis was uric acid . The hereditary and seasonal nature of the
affliction had been remarked upon
by Galen (A.O. 120) , the most notable disciple of Hippocrates, who,
in his writings 600 years previously,
had also noted the association of
the acute attacks with various

Fig. I- True gout in the great toes of an ancient Greek.
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stresses- chiefly those of a bibulous, gastronomic or sexual nature.
He also pointed out correctly that
eunuchs and women who had not
reached the menopause never fell
victim. The distinguished contemporaries of Hippocrates-King Priam
of Troy, King Oedipus of Thebes
and the hero Achilles- were all, he
reported, sufferers from gout. The
Roman poet Lucian wrote a popular burlesque tragedy on the powers of the Goddess Podagra and
the ineffectiveness of human treatment. Tophaceous deposits were
noticed and commented upon by
most of the early medical writers,
including the second century physician Soranus of Ephesus, who
advocated their surgical removal in
selected cases. It was the great
English chemist William H . Wollaston, F.R.S., who, in the 18th
century, was able to demonstrate
that a tophus removed from his
own ear was composed of uric acid.
Prognosis

With regard to the prognosis of
the disease, Aretaeus rightly pointed

out that, once gout is declared in
a person, "the disease sticks to him
until death." Hippocrates stated
that those affected "who are aged
and have tophi in their joints and
those who have led a hard life and
whose bowels are constipated, are
beyond the power of medicine to
cure .. . . Persons under other circumstances may be cured by a
skillful physician." He pointed out
that the younger the sufferer, the
poorer the outlook. These views
remained largely unaltered until
comparatively modern times, when
uricosuric preparations were introduced and the disease process at
last became controllable by chemical means. It is interesting to note
that 50 years ago most insurance
companies took an extremely unfavourable view of the prognosis in
victims of gout, whilst today the
majority of adult cases are accepted
at normal rates. In 1959 John H.
Talbott and Abraham Lilienfeld
showed that the mortality rate
among gouty sufferers in the United
States was similar to that in the
general population.

Classification

Classification remained simple
until the 18th century, because the
early Greek writers regarded all
affections of joints, except those of
directly traumatic origin, as being
of the same basic "gouty" nature,
despite evidence in the surviving
works of Hippocrates that he may
have recognised a difference between the syndromes of true gout
and rheumatic fever. If Hippocrates did recognise a distinction,
it was forgotten by his successors
until the 17th century. Even then,
Sydenham's views were not universally accepted, if we may judge
from his dry remark, "Doubtless
gout and rheumatism were often
confounded by the ancient Greek
physicians; a point which is still
equally applicable to the great
pundits of our present day." Until
that time, the generic term used
was "arthritis," and its evident
varieties were merely classified according to an anatomical plan :
podagra, when it afflicted the foot
(Fig. 3) ; chiagra, the hand ; gonagra, the knee; and so on, through-
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Fig. 2-P ossibly the earliest p rinted
work on gout ( 1577 ) .

F ig. 3- A personal reminiscence of podagra (1799 ) by James G ill ray.
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Fig. 4-Sydenham's notebook ; in possession of the Royal College of Physicians.

out the joints of the body, and including sciatica. This simple convenient authoritarian method of
classification persisted unchanged
for the next thousand years, although occasional murmurs of
doubt could be heard , as when Dr.
Andrew Boorde, who was one of
King Henry YUi's physicians,
warned (1547) that, despite general belief, "All jointe illnesses are
not the goute. " He added in an independent vein, "It is extremely
difficult for a physician who puts
too much trust in what he reads to
form a proper decision from what
he sees," a sentiment which we can
still endorse.
With the 18th century came the
fashion started by Carolus Linnaeus,
the great botanist, for evolving "systems" of classification. Articular
affections received considerable at-

Fig. 5- "Comfort in the Gout" (J. Rowl andson, 1785) .
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tention from leaders of the profession throughout Europe. Gout then
became subdivided into 14 varieties
and species with further subdivisions according to its seasonal variations and its association with
other disorders. Its visceral manifestations also became more generally known and were classified
under the headings "Anomalous,"
"Irregular," "Retrocedent" or "Misplaced" Gout. Such classifications,
however, perpetuated the belief
that gout was the basic prototype
of all joint affections other than
those attributable to rheumatic
fever or Sydenham's further indeterminate class of "scorbutic affections of the joints." It was just over
a century ago (1859) that Garrod
(who should be known as the
"Father of Modern Rheumatology" ), as the result of his studies
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in morbid anatomy, was able to
differentiate between the clinical
entities of rheumatoid arthritis, for
which he suggested the name, and
osteoarthritis. Modern classification
of joint affections bas become
complicated once more with the
identification of an increasing number of disease processes. The syste m most generally accepted is the
one proposed by the A.M.A. , which
seems sufficiently flexible to accommod ate further increases in
knowledge as they occur and includes the various types of gout
currently recognised .
Pathology
The pathology of gout began to
arouse interest subsequent to the
acceptance of Thomas Sydenham's
reintroduction of sound observational medicine into England towards the end of the 17th century.
He clearly and unambiguously
described the clinical fe atures of
gout and its associated pathology,
such as tophus formation ( "stony
concretions like unto chalk") in
the tissues around joints and in the
cartilage of nose and ear, leading
to chronic and sometimes crippling
conditions-e.g. , urinary stone ,
heart disease and apoplexy (Fig.
4) . His influence quickly spread
throughout Europe with the help of
such distinguished admirers as the
Dutchman Hermann Boerbaave and
his pupils William Cullen and Sir
John Pringle of Edinburgh and,
later, Gerard Van Swieten and
Baron Anton Von Stoerk of Vienna.
Increasing interest in the pathology
of gout coincided with the development of the microscope and the
general introduction of postmortem
examination , which, until that time,
had been discouraged by the
Church. This conjunction of circumstances culminated in the first
great work on morbid anatomy
(1761) produced by Giovanni Morgagni, the Italian founder of that
subject. His description of the pat hology of gout was carried further
by Jean Bichat, the father of

French scientific medicine, in bis
splendid work Anatomie Pathologique of 1825.
The interesting "mediaeval" character, Paracelsus, half alchemistquack and half genius, was the
first to suggest that gout might
not be a product of humoral derangement, but might instead be a
" tartarous" chemical abnormality ;
proof was lacking, however. The
first step towards an accurate metabolic conception of the disease
was taken when the Swedish apothecary Karl Wilhelm Scheele di scovered uric acid (1776) in the
course of chemical researches
carried out after business hours in
the kitchen of bis herb shop . The
next step was Wollaston's discovery, noted above, that gouty tophi
contained uric acid . It was this
knowledge which led to Garrod's
demonstration ( 1848) that uric
acid was the eminence grise behind the various manifestations of
gout. For that purpose, he devised
bis famous "thread test," one of
the first bedside chemical tests ever
used for diagnostic purposes.
Subsequently, much further light
was thrown upon the metabolic
complexities of gouty metabolism
as the result of the monumental
work of the German chemist Emil
Fischer (1852-1919) , who first
established the relationship of uric
acid to purine protein bodies. He
worked out the family tree of gout
and showed that the purine nucleus
was the common ancestor of all
the metabolic products of the disease. This was the scientific foundation of our present improved
understanding of the disease process, which has been facilitated by
advances in such important aids as
micromethods of blood analysis
and isometric labelling.
Treatment

The general plan of treatment
for gout systematised by the Hippocratic physicians was based upon
their conception of humoral pathology and varied very little until

comparatively recent times. Its objective was to evacuate the offending matter from the body through
all available routes by purging,
sweating, diuresis and bleeding.
The system would then have to be
built up by proper diet and exercise so that the humoral defects
would right themselves and the
body would act, henceforth, as its
own physician. With minor and
fashionable variations, that system
of management altered but little
until the middle of the last cen tury
(Fig. 5) .
The modem treatment of gout
depends upon the use of powerful
anti-inflammatory substances to
subdue its acute episodes . More
basically important, however, are
the long-term measures which must
also still be used between attacks,
with the objective of lowering the
blood level of uric acid and so, in
time, preventing further attacks.
Such "interval treatment" may
have to be maintained almost
permanently in certain patients by
means of both medication and
regime.
Of the anti-inflammatory substances used for the former purposes, colcbicine is still probably
the most specific. Until 1884 this
alkaloid was obtained from the
corm of the autumn crocus, Colchicum autumnale (Fig. 6). It was
known by the name of hermodactyl
to the ancient Greeks, who employed it as a powerful purgative.
As purgation was considered by
them to be the easiest and best
method of eliminating the " peccant gouty humour," they evidently
obtained good therapeutic results,
although there is no convincing evidence that they recognised the specific effect of hermodactyl upon the
disease. During the Middle Ages
polypharmacy became the fashion ,
but small amounts of hermodactyl
were still used in purgative prescriptions throughout Europe. It
was Sydenham who eventually decided that purgation was inappropriate as a therapeutic measure in
gout. Such was his influence that
5
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the use of substa nces for catharsis,
including colchicum, was discontinued for the next 200 years . As
alternative treatment, dietetic measures, bleeding, blistering, diuresis
and sweating, together with moderate physical exercise and a quiet
routine life, were reverted to with
some degree of success. The names
of the English physici ans William

Cadogan, George Cheyne and William Heberden were particul arly
associated with such regimes during the 18th century.
Reintroduction of colchicum for
the treatment of gout is generally attributed to Yon Stoerk of
Vienna ( 1763) . It seems, however,
that he advoca ted its use principally for the treatment of oedema

Fig. 6-Colchicum , or the Meadow Saffron. From a French herbal.
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of cardiac origin ; its value in
the gout remained forgotten until
a French quack introduced his
secret remedy L 'Eau d'Husson
about 1780. This enjoyed immediate success among the many distinguished sufferers in Europe. The
Prince Regent of England , the
"First Gentleman of E urope," was
a great sufferer, but his physicians refused to allow him to obtain a supply, as it was a "patent
medicine of unknown composition ." Eventually, he used hi s royal
prerogative, saying, "Gentlemen, I
have taken your half-measures long
enough to p lease you. . . . From
now on I shall take colchicum to
please myself." As he had previously been ingesting l ,200 drops
of la ud anum daily without relief of
pain, the immediate results of the
beneficial effect of colchicum were
fe lt indirectly throughout the Continent. The success of this medicament led to a spate of other sec ret
remedies such as the famous "Portla nd Powder," but none of them
achieved permanent success. It is a
curious fac t, however, that although most of the world's leading
physicians thereafter adopted the
use of colchicum , an influential
minority, which included the celebrated Frenchman Armand Trousseau, held out aga inst it in th e
belief that its use would merely
suppress the acute manifestation s
by driving them into other part s
of the bod y, thereby increasi ng the
underl ying viscera l gravity of the
disease.
Other substances of quite recent
introduction which are used in gout
for their anti-inflammatory and
ana lgesic properties are: a) phenyl butazone compounds ; b) indomethac in ; and c) steroid hormones,
although these are now seldom
employed.
For the long-term control and
ma nagement of gouty arthritis, in
addition to instituting dietetic regime it was necessary to find substances capable of lowering the
level of the uric acid present in the
sufferer's blood stream . The first
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substance of this type was cinchophen (atophan) which was synthesised as early as 1887 in Germany and was introduced into
clinical medicine for this purpose
by W. Weintraud of Berlin in
1911. For a time it served its purpose, but eventually its often dangerous side effects severely limited
its use. The only alternative was
sodium salicylate which for this
purpose, however, had to be giwe n
in a dosage so high that most
patients were un able to tolerate it
for long.
Jt was not until 1948-exactly
a century after the discovery of
uric acid as th e fons et origo of
the gouty state- th at a satisfactory
uricosuric substance was discovered, as a side issue, during the
course of ex periments designed to
broaden the spectrum of penicillin.
Jn that yea r William Q. Wolfson
and his colleagues noted that carinamide, give n in doses of 10-20
gm, would lower th e blood level of
uric acid whilst increasing total
urinary excretion. This dosage level
proved too high for safety, however, and it was not until its synthetic proge ny probenecid was develo ped in 195 1 that these results
co uld be obtained with comparative
immunity from side effects. In
1959 benemid was introduced into
clinical practise and since then has
proved to be a safe and effective
uricos uri c age nt. Synthetic varia nts continue to be add ed to our
therapeutic armamentarium for in ducing a prolonged negative uric
balance in the body.
In 1966 a new type of substance, all op urinal, was introduced
wh ich, by enzy me act ion , is able to
effectively suppress the synth esis
of uric ac id in th e body and eliminate purines in their intermediate
synthetic stages of xa nthine and
hypoxanthine, a process which
does not appear to be followed by
unwanted side effects. An impressive secondary result of allopurin al
administration is the gradual reabsorption of fully formed tophi .
Other methods of treating gout

which have had thei r vogue at
times throughout the ages include
magic symbolism, use of the lodestone (magnetism) , counterirritation such as produced by burning fl ax (moxa) or the cautery,
hyp notism , hydrotherapy and use
of electric currents. The earliest
use of electrotherapy was described by the Rom an ph ys ician
Scribonius Largus (A.D . 46), who
sa id th at, "For any type of gout
... a live black torpedo fish should
be pl aced under the feet. The patient must stand on a moist shore
washed by th e sea, and he should
stay like this until his whole leg up
to the knee is numb .. .. " This
treatment was later th e subject of
a commentary by G alen.
Medicinal "specifics" were a
legitimate part of th e stock-in-trade
of many celebrated physici ans
in the past for the treatment of a
number of diseases, including th e
gout. Most of these spec ifics, including th e " Gout Cordial " advocated by Hermann Boerh aa ve, the
" Batavian Hippoc rates," contained,
amon g other ingredients, white
hellebore (Vera /rum album.) or
guaiac um bark. The hosts of itinerant quacks and empirics who
pera mbulated E urope also used
mine ral substances such as antimony, arsenic and mercury which
could be-and often were- hi ghl y
dangerous. During th e acute phase
of a gouty attack, opiates would
naturally be called for by th e sufferer, although, strangely, most orthod ox medical opinion during the
17th and 18th centuries frowned on
th e practise, as it was thought th at
th e disease would only be temporarily miti ga ted and would be likely
to recur thereafter in a more malignant and lastin g guise . The custom
of hot and cold bathin g practised
by the anci ent Greeks led directl y
to the later development of the
va rious mineral water spas which
attracted the wealthier sufferers for
treatment durin g the 18th and 19th
centuries-and still do. To P aracelsus, who first suggested a chemical origin for the disease. these

healing springs represented nature's
laboratories, revealing to men the
hidden virtues and powers of the
vix medicalrix naturae.
The use of external applications
was universal during the Middle
Ages and the Rena issa nce , and
secret recipes for such unguents
and plasters, if th e ingredients were
sufficientl y exotic or expensive,
were often used as gifts by suppliants to ingrati ate monarchs and
potentates. During the 18th century, however, external remedies
were considered undesirable, as
they tended to "fix the inflamm ation" in the affec ted joints; a policy
of laissez-fa ire concerning the outsid e of the body was considered
preferable.
It is interesting to note th at the
treatment of go ut- the best documented disease of mankind and
one which, Sydenham remarked ,
" . .. destroys mo re rich th an poor
persons, and more wise men than
fools " -remained basically unch anged from the earli est days
until the first quarter of the last
century.
Wine
From ea rl y times it had been
remarked that the stresses put
upon metabolism by heavy eatin g
or drinking would often culmin ate
in an episode of go ut. Hippocrates
and his followers , therefore, pl aced
great importance upon moderation
in both food a nd wine. Curiously,
he believed that the heav ier ,
sweeter wines of Salerno and the
South were to be preferred.
In 1688 the French wines popular in England began to be fortified
with brand y as a prese rvative, and
the incidence of go ut markedly
rose. According to one authority,
"Burgundy is, of all wines, the
most certain fuel to the go ut. " In
1703 gouty Queen Anne of England concluded the Trea ty of
Methuen whereby port wine was
substituted for the French wines .
It became very popul ar, according
to Richard Mead , " as an antidote
7
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to the damp climate and fogs of
England, the inhabitants being at
that time unaware of the canker
that lurks in every glass for the
gouty subject. " From the time of
the legendary invention of champagne by a French Benedictine
monk in 1718 , there was almost
unanimous agreement within the
Faculty that this wine above all
others would precipitate attacks of
gout. The 19th century gave rise
to considerable learned and pseudolearned literature upon the subject.
In a lighter vein one may quote a
letter of James Russell Lowell
from Boston . He wrote: "I call
my gout the unearned increment
from my grandfather's madeira,
and think how excellent it must
have been- I sip it from the bin
of fancy , and wish he had left to
me the cause instead of the effect."
As Benjamin Franklin pointed out,
the truth of the matter, if we
exclude those rare persons who
have an allergic sensitivity to certain wines, may have been enunciated by Thomas Sydenham when
he said ( 1682) , " If you drink wine
you get the gout ; if you do not
drink wine-the gout has you."
Historic Effects

Reference was made earlier to
the effect that gout appears to have
exercised upon world affairs. Several of the great Ren aissance Italian
Medici rulers who were sufferers
serve to illustrate the association
between outstanding ability and
gouty diathesi s which has been remarked upon throughout the ages.
Of "Piero ii Grottoso" (Peter the
Gouty) it was written that his disease "caused him often to leave the
affairs of his state to others less
worthy." The great Holy Roman
Emperor Charles V, who suffered
his first attack at the age of 28,
eventually was forced to the unprecedented step of abdicating in
favo ur of hi s son Philip II of Spain,
who married Mary Tudor, Queen
of England, and , in turn, died
crippled of the same complaint.
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Had not the great Lord Burghley,
Chancellor of England, himself
been incapacitated with an attack
of the same disease, he would have
been able to prevent that marriage
which brought such misfortune to
his country.
The well-known 17th century
statesman Sir William Temple
pointed out that the gout often
affected the outlook and policy
of rulers, saying, "I have seen the
councils of a very great country
(France) grow bold or timorous
according to the fits of gout on its
Governor. " A final example, nearer
home, may be of interest. It concerns the English Prime Minister,
William Pitt, First Earl of Chatham, who by 1763 had concluded
successfully the seven years' struggle with France for the sovereignty
of the New World. The cost of
such victory was high, and it was
thought that the Colonies should
share it. So, taking advantage of
Pitt's absence during an attack of
gout, Parliament passed the Stamp
Act, which threw much of the expense upon the American Colonies
-without their consent, however.
On his return Pitt indignantly had
it repealed, but during a further attack of gout his colleagues substituted a heavy colonial duty on
tea to raise the revenue required.
This culminated in the famous
Boston Tea Party with its wellknown results . Pitt was abetted in
his peaceful efforts by his gouty
American friend and colleague
Benjamin Franklin, who was said
to have introduced the first corms
of colchicum into the colonies on
his return to Philadelphia, where
he wrote his well-known and amusing Dialogue between Benjamin
Franklin and the Gout. It is interesting to speculate on the relationship our two great countries
would be enjoying had the rediscovery of colchicum for the treatment of gout been advanced by 25
years and the War of Independence
therefore not taken plaE:e!
It ·had long been suspected that
gout might be a disease of varying

origins, but it has only been during
the present century that primary or
acquired gout and hereditary gout
have been clearly defined and differentiated. A considerable number
of secondary types are now recognised. Several are of iatrogenic
nature, whereas others result from
disorders of the blood , the bone
marrow and the metabolism, as well
as from associated specific defects
such as those in the Lesch-Nyhan
Syndrome of children. Increasing
knowledge of gout's chemical secrets, however, is resulting in improved treatment, and we can now
assert that gout is perhaps the
disease of which we have the most
detailed specific understanding and
the most effective control. With
cooperation from the sufferer and
a mild dietary regime, we can now
prevent any damage which has already occurred from progressing
and, thus, avoid recurrent or progressive deterioration. In almost
every case we can now terminate
the occurrence of the painful
acute attacks by use of modern
chemotherapy .

